Neoplasm Treatment Market Trends

  • Report ID: 3898
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Neoplasm Treatment Market Trends

Growth Drivers

  • Increasing Exposure to Smoke - Any area of the body can be affected as a result of cigarette smoking. Excessive smoking is injurious to health, and can make the condition worsen with time. Therefore, it is projected to surge the growth of the global neoplasm treatment market. According to the American Cancer Society, nearly 20 percent of cancers, and 30 percent of all cancer deaths are owing to the smoking in the United States.

  • Increasing Geriatric Population - The incidence rates of neoplasms increase with the rise in the elderly population’s percentage. With the increasing age, the        cells in the body get damaged, and are expected to drive the market’s growth. As per the reported data, in the year 2050,  more than 70 percent 80% of the world's old people is anticipated to live in low- and middle-income countries.

  • Increasing Exposure to Smoke - Any area of the body can be affected as a result of cigarette smoking. Excessive smoking is injurious to health, and can make the condition worsen with time. Therefore, it is projected to surge the growth of the global neoplasm treatment market. According to the American Cancer Society, nearly 20 percent of cancers, and 30 percent of all cancer deaths are owing to the smoking in the United States.

  • Increasing Geriatric Population - The incidences rates of neoplasm increase as the rise in the elderly population percentage. With the increasing age, the        cells in the body gets damaged, and are expected to drive the market’s growth. As per the reported data, in the year 2050, more than 70 percent of the world's old people is anticipated to live in low- and middle-income countries.

Challenges

  • High Cost for the Treatment of Neoplasm - There are treatment options that are critical and needed to be adopted in critical conditions such as surgery. Moreover, the cost charged by the doctors are high for the complex procedures. Therefore, it is expected to hamper the market’s growth in the upcoming years.
  • Lack of awareness among people in low and middle-income countries for these treatment
  • Lack of medical reimbursement policies for treatment of Neoplasm

Neoplasm Treatment Market: Key Insights

Base Year

2022

Forecast Year

2023-2035

CAGR

~10%

Base Year Market Size (2022)

~ USD 170 Billion

Forecast Year Market Size (2035)

~ USD 400 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Base Year

2024

Forecast Year

2025-2037

CAGR

10.2%

Base Year Market Size (2024)

USD 206.64 billion

Forecast Year Market Size (2037)

USD 730.42 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3898
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of neoplasm treatment is estimated at USD 241.74 billion.

The neoplasm treatment market size was over USD 206.64 billion in 2024 and is anticipated to cross USD 730.42 billion by 2037, growing at more than 10.2% CAGR during the forecast period i.e., between 2025-2037. Surging change in genetic mutations, increasing geriatric population will boost the market growth.

North America industry is anticipated to account for largest revenue share by 2037, attributed to rising cases of cancer in the region.

The major players in the market are Thermo Fisher Scientific Inc., Bayer AG, Merck & Co., Inc., Novartis AG, Abbott Laboratories, Exelixis, Inc., Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche, Amgen Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample